Back to Journals » OncoTargets and Therapy » Volume 10

The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer [Retraction]

Authors Li X, Song C, Huang G, Sun S, Qiao J, Zhao J, Zhao Z, Li M

Received 26 April 2017

Accepted for publication 26 April 2017

Published 4 May 2017 Volume 2017:10 Pages 2425—2426

DOI https://doi.org/10.2147/OTT.S140498

Li X, Song C, Huang G, Sun S, Qiao J, Zhao J, Zhao Z, Li M. The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer. OncoTargets and Therapy. 2017;10:1735–1742.

The authors have advised us of concerns about the specificity of the primary antibody which have resulted in misleading and false results.
 
This Retraction relates to this paper

 

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Other articles by this author:

Disruption of human papillomavirus 16 E6 gene by clustered regularly interspaced short palindromic repeat/Cas system in human cervical cancer cells [Retraction]

Yu L, Wang XL, Zhu D, Ding W, Wang L, Zhang C, Jiang X, Shen H, Liao S, Ma D, Hu Z, Wang H

OncoTargets and Therapy 2017, 10:2835-2836

Published Date: 2 June 2017

FAM172A expression in circulating tumor cells for prediction of high-risk subgroups of colorectal cancer [Retraction]

Xu C, Zhang C, Wang H, Yang H, Li G, Fei Z, Li W

OncoTargets and Therapy 2017, 10:2411-2412

Published Date: 3 May 2017

miR-32 functions as a tumor suppressor and directly targets SOX9 in human non–small cell lung cancer [Retraction]

Zhu D, Chen H, Yang X, Chen W, Wang L, Xu J, Yu L

OncoTargets and Therapy 2016, 9:6379-6380

Published Date: 20 October 2016

MiR-206 functions as a tumor suppressor and directly targets K-Ras in human oral squamous cell carcinoma [Retraction]

Lin FO, Yao LJ, Xiao J, Liu DF, Ni ZY

OncoTargets and Therapy 2016, 9:6377-6378

Published Date: 20 October 2016

Expression of PER, CRY, and TIM genes for the pathological features of colorectal cancer patients [Retraction]

Wang Y, Cheng Y, Yu G, Jia B, Hu Z, Zhang L

OncoTargets and Therapy 2016, 9:5699-5700

Published Date: 20 September 2016

Post-dural puncture headache [Retraction]

Ghaleb A, Khorasani A, Mangar D

International Journal of General Medicine 2016, 9:173-174

Published Date: 3 June 2016

Retraction

Li JZ, Zhang Y, Wen B, Li M, Wang YJ

OncoTargets and Therapy 2016, 9:613-614

Published Date: 4 February 2016

Retraction

Gu J, Sun R, Shen S, Yu Z

OncoTargets and Therapy 2016, 9:615-616

Published Date: 4 February 2016

Randomized comparative trial of cervical block protocols for pain management during hysteroscopic removal of polyps and myomas [Erratum]

Lukes AS, Roy KH, Presthus JB, Diamond MP, Berman JM, Konsker KA

International Journal of Women's Health 2015, 7:871-872

Published Date: 3 November 2015

Diagnosis and management of miliary tuberculosis: current state and future perspectives [Retraction]

Ray S, Talukdar A, Kundu S, Khanra D, Sonthalia N

Therapeutics and Clinical Risk Management 2015, 11:1457-1458

Published Date: 28 September 2015

A cross-sectional study on perception of stigma by Chinese schizophrenia patients [Retraction]

Ren ZB, Wang HQ, Feng B, Gu CY, Ma YC, Chen H, Li BL, Liu LY

Neuropsychiatric Disease and Treatment 2015, 11:895-896

Published Date: 1 April 2015

A cross-sectional study on perception of stigma by Chinese schizophrenia patients [Expression of concern]

Ren ZB, Wang HQ, Feng B, Gu CY, Ma YC, Chen H, Li BL, Liu LY

Neuropsychiatric Disease and Treatment 2014, 10:1333-1334

Published Date: 18 July 2014

Biologic targeting in the treatment of inflammatory bowel diseases [Retraction]

Bosani M, Ardizzone S, Porro GB

Biologics: Targets and Therapy 2014, 8:39-40

Published Date: 31 January 2014

Interaction of recombinant and native Cav2.3 E-/R-type voltage-gated Ca2+ channels with the molecular chaperone Hsp70 [Corrigendum]

Radhakrishnan K, Krieger A, Tevoufouet EE, Dietz GP, Nagel F, Bähr M, Hescheler J, Schneider T

Journal of Receptor, Ligand and Channel Research 2014, 7:1-2

Published Date: 17 January 2014

Female stalking: a systematic review [Retraction]

Carabellese F, La Tegola D, Alfarano E, Tamma M, Candelli C, Catanesi R

Research and Reports in Forensic Medical Science 2014, 4:1-2

Published Date: 31 December 2013

Erratum

Parizek M, Douglas TEL, Novotna K, Kromka A, Brady MA, Renzing A, Voss E, Jarosova M, Palatinus L, Tesarek P, Ryparova P, Lisa V, dos Santos AM, Bacakova L

International Journal of Nanomedicine 2012, 7:5873-5874

Published Date: 26 November 2012

Retraction

Cárdenas WH, Mamani JB, Sibov TT, Caous CA, Amaro E Jr, Gamarra LF

International Journal of Nanomedicine 2012, 7:5107-5108

Published Date: 21 September 2012